Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study., Monge, Susana, Humphreys James, Nicolay Nathalie, Braeye Toon, Van Evercooren Izaak, Holm Hansen Christian, Emborg Hanne-Dorthe, Chiara Sacco, Mateo-Urdiales Alberto, Castilla Jesús, et al. , Influenza Other Respir Viruses, 2024 Apr, Volume 18, Issue 4, (2024)